Corporate News Cassava Sciences GAAP EPS of -$0.58 beats by $0.30 by Contributor since / Followers 3 months ago Cassava Sciences press release (NASDAQ:SAVA): Q3 GAAP EPS of -$0.58 beats by $0.30. $149.0 Million in Cash and Cash Equivalents at September 30, 2024. Expected To Support Operations Into 2026 Tags: SAVA Continue Reading Previous Tesla lands higher targets from BofA with regulatory hurdles looking lowerNext Datadog Q3 revenue soars, raises 2024 outlook Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ